1
T Cell Mediated Adaptive Therapy for Her2-positive Neoplasms of Digestive System
Condition(s):Esophageal Cancer; Gastric Cancer; Pancreatic Cancer; Liver Cancer; Gallbladder Cancer; Bowel CancerLast Updated:January 25, 2016Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.